Diabetes News and Research

Latest Diabetes News and Research

Study links large waistline to increased risk of heart problems and type 2 diabetes

Researchers at Eastern Virginia Medical School’s Strelitz Diabetes Center and the school’s department of physiological sciences have published research showing a strong link between a large waistline and increased risk of Type 2 diabetes and cardiovascular disease.

14 Dec 2010

Health report card for NSW

The latest report on NSW health shows that it is better than most in heart disease and cancer statistics. However 60% of the state are overweight or obese says the report and 70% of the NSW adults say they have been diagnosed with long-term illnesses.

14 Dec 2010

Tolerx commences TRX518 Phase 1 trial in malignant melanoma

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.

14 Dec 2010

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.

14 Dec 2010

Workplace interactions may educate people about organ donation process

Face-to-face workplace interactions may be the best way to educate and encourage people to consider becoming organ donors, according to new research from Purdue University.

14 Dec 2010

Lexicon reports top-line results from LX2931 Phase 2a study in rheumatoid arthritis

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.

14 Dec 2010

Unigene enters agreement with GSK to advance oral PTH Phase 2 program for osteoporosis

Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.

14 Dec 2010

UnitedHealthcare's care management solution will improve diabetes prescription drug adherence: Study

HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that UnitedHealthcare's innovative care management solution in the Phoenix market will improve diabetes prescription drug adherence. According to the recent West Health Plan Analysis, the use of non-physician, credentialed providers is intended to create virtual medical homes that allow non-traditional providers, such as pharmacists, wellness coordinators and lifestyle coaches, to recommend and coordinate necessary prescription adjustments.

14 Dec 2010

We live longer, but not healthier

Increased life expectancy in the United States has not been accompanied by more years of perfect health, reveals new research published in the December issue of the Journal of Gerontology.

14 Dec 2010

Diamyd Medical issues new shares to cover social security contributions for employee stock option plans

In connection with the exercise of employee stock options in the plans 2007/2010 and 2008/2011, Diamyd Medical is issuing 155,352 new shares of series B to cover social security contributions for the plans. The shares are issued with support of underlying warrants that covers the company's obligations within the scope of the programs.

14 Dec 2010

Roche launches new xCELLigence System RTCA HT Instrument

The new xCELLigence System RTCA HT Instrument from Roche Diagnostics rounds out the company's portfolio in real-time cell analysis with a high-throughput product. The new instrument merges the power and flexibility of xCELLigence System technology with high-throughput analyses and workflows for automated screening applications.

From Roche Sequencing and Life Science 14 Dec 2010

The Affordable Care Act can benefit 18.3 million men and women ages 50 to 64

18.3 million men and women ages 50 to 64 stand to benefit from provisions in the Affordable Care Act, assure that all health insurance provides a standard comprehensive benefit, prevent insurers from denying coverage or charging higher premiums to people with pre-existing conditions, and eliminate lifetime and annual limits in health insurance policies, according to a new Commonwealth Fund report released today.

14 Dec 2010

Even small amount of alcohol increases chances of developing cancer

When raising your glass at this year's holiday toast, choose your beverage wisely, say experts at The University of Texas MD Anderson Cancer Center. If adults wish to drink alcohol, they should select drinks low in calories and alcohol content to limit cancer risk.

14 Dec 2010

Reversible two-step binding mechanism to stop cancer cell growth

What makes cancer cells so dangerous is that they grow in an unregulated way and proliferate much faster than other cells. The proteasome, a large protein complex, plays a key role in this process: By breaking down used proteins for recycling, it clears the way for the next cycle.

14 Dec 2010

ACCESS receives $6.7M NIH Clinical and Translational Science Award

Access Community Health Network (ACCESS) has received a $6.7 million Clinical and Translational Science Award grant from the National Institutes of Health (NIH) to construct a community-based research center. The goal of the center's research will be to engage the community and reduce racial and ethnic disparities in health care.

14 Dec 2010

Soda taxes – would they do any good?

According to new research from Duke-National University of Singapore (NUS) Graduate Medical School imposing higher taxes on sodas and other sweetened drinks would lead to only minimal weight loss among most people and would have no effect on weight among consumers in the highest and lowest income groups.

13 Dec 2010

Fat or obese – What’s in a name?

The question of whether the term ‘fat’ is more appropriate than ‘obese’ was raised in an Australian study that confirmed the former is the “lesser of two evils”. The study from University of NSW study which looked at public perceptions surrounding these words has found that, while both are unwelcome, obese was viewed more negatively.

13 Dec 2010

$Indian study confirms vitamin D deficiency as risk factor for hip fracture$

Indian study confirms vitamin D deficiency as risk factor for hip fracture

A study from New Delhi India has revealed high rates of vitamin D deficiency among hip fracture patients, confirming the conclusions of similar international studies which point to vitamin D deficiency as a risk factor for hip fracture.

13 Dec 2010

WellDoc DiabetesManager solution integrated with leading EHR system

WellDoc®, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, today announced the first integration of a clinically tested mHealth coaching platform with a leading electronic health records (EHR) system. The integration of the WellDoc DiabetesManager® solution into an EHR will streamline and enhance patient care by combining a best-in-class patient coaching platform and clinical decision support with the workflow efficiency of an EHR system.

13 Dec 2010

Cedarlane to distribute TGR's new ELISA-One technology assay reagents in Canada and the US

TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Cedarlane Laboratories of Burlington, ON, Canada, a leading supplier of Life Science research reagents in North America.

13 Dec 2010